Recently, the interaction between CD150 and RP105 has been shown to regulate Akt and MAPK signaling in chronic lymphocytic leukemia B cells in vitro and in vivo (Gordiienko et al., 2017). This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.